
One takeaway of FE Healthcare Summit & Awards 2025: Risk capital to fund innovation in pharma limited in India
The risk capital, which is used to fund innovation in the pharma sector, is limited in India, said Rajeev Singh Raghuvanshi, Drug Controller General of




